BACKGROUND: Methamphetamine (Meth) abuse continues to be a major illicit drug of abuse. Neuroimaging findings suggest that Meth is neurotoxic and may alter various brain structures, but the effect of Meth on the aging brain has not been studied. AIM: The aim was to determine regional volumes of cortical gray matter in the brains of adult Meth users versus healthy control subjects, and their interaction with age and Meth-usage variables. DESIGN: Cross-sectional study SETTING: Magnetic resonance imaging (MRI) Research Center located in a university-affiliated hospital. PARTICIPANTS: Thirty-four Meth-dependent subjects (21 men and 13 women; ages 33.1 ± 8.9 years), diagnosed according to DSM-IV criteria, and 31 healthy non-Meth user comparison subjects (23 men and 8 women ages 35.7 ± 8.4 years). MEASUREMENT: Regional gray matter volumes were segmented automatically in all subjects and evaluated in relation to age, using high-resolution MRIs at 3.0 Tesla. FINDINGS: After adjustment for the effects of cranium size, the Meth users showed enhanced cortical gray matter volume loss with age in the frontal (analysis of covariance interaction P = 0.02), occipital (interaction P = 0.01), temporal (interaction P < 0.001) and the insular lobes (interaction P = 0.01) compared to controls, independently of Meth-usage patterns. Additionally, Meth users showed smaller gray matter volumes than control subjects in several subregions (dorsolateral prefrontal: P = 0.02; orbitofrontal: P = 0.03; prefrontal: P = 0.047; superior temporal: P = 0.04). CONCLUSIONS: Methamphetamine users appear to show increased cortical gray matter loss with age which raises the possibility of accelerated decline in mental functioning.
BACKGROUND:Methamphetamine (Meth) abuse continues to be a major illicit drug of abuse. Neuroimaging findings suggest that Meth is neurotoxic and may alter various brain structures, but the effect of Meth on the aging brain has not been studied. AIM: The aim was to determine regional volumes of cortical gray matter in the brains of adult Meth users versus healthy control subjects, and their interaction with age and Meth-usage variables. DESIGN: Cross-sectional study SETTING: Magnetic resonance imaging (MRI) Research Center located in a university-affiliated hospital. PARTICIPANTS: Thirty-four Meth-dependent subjects (21 men and 13 women; ages 33.1 ± 8.9 years), diagnosed according to DSM-IV criteria, and 31 healthy non-Meth user comparison subjects (23 men and 8 women ages 35.7 ± 8.4 years). MEASUREMENT: Regional gray matter volumes were segmented automatically in all subjects and evaluated in relation to age, using high-resolution MRIs at 3.0 Tesla. FINDINGS: After adjustment for the effects of cranium size, the Meth users showed enhanced cortical gray matter volume loss with age in the frontal (analysis of covariance interaction P = 0.02), occipital (interaction P = 0.01), temporal (interaction P < 0.001) and the insular lobes (interaction P = 0.01) compared to controls, independently of Meth-usage patterns. Additionally, Meth users showed smaller gray matter volumes than control subjects in several subregions (dorsolateral prefrontal: P = 0.02; orbitofrontal: P = 0.03; prefrontal: P = 0.047; superior temporal: P = 0.04). CONCLUSIONS:Methamphetamine users appear to show increased cortical gray matter loss with age which raises the possibility of accelerated decline in mental functioning.
Authors: Ain Chung; In Kyoon Lyoo; Seog Ju Kim; Jaeuk Hwang; Soojeong C Bae; Young Hoon Sung; Minyoung E Sim; In Chan Song; Jihyun Kim; Kee Hyun Chang; Perry F Renshaw Journal: Int J Neuropsychopharmacol Date: 2006-12-06 Impact factor: 5.176
Authors: Julia M Lappin; Kevin Morgan; Craig Morgan; Gerard Hutchison; Xavier Chitnis; John Suckling; Paul Fearon; Philip K McGuire; Peter B Jones; Julian Leff; Robin M Murray; Paola Dazzan Journal: Schizophr Res Date: 2006-01-31 Impact factor: 4.939
Authors: Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Ain Chung; Young Hoon Sung; Jihyun Kim; Do-Hoon Kwon; Kee Hyun Chang; Perry F Renshaw Journal: Int J Neuropsychopharmacol Date: 2005-06-28 Impact factor: 5.176
Authors: S M Berman; B Voytek; M A Mandelkern; B D Hassid; A Isaacson; J Monterosso; K Miotto; W Ling; E D London Journal: Mol Psychiatry Date: 2007-10-16 Impact factor: 15.992
Authors: Angelica M Morales; Buyean Lee; Gerhard Hellemann; Joseph O'Neill; Edythe D London Journal: Drug Alcohol Depend Date: 2012-03-22 Impact factor: 4.492
Authors: Samantha J Fede; Carla L Harenski; Jana Schaich Borg; Walter Sinnott-Armstrong; Vikram Rao; Brendan M Caldwell; Prashanth K Nyalakanti; Michael R Koenigs; Jean Decety; Vince D Calhoun; Kent A Kiehl Journal: Psychopharmacology (Berl) Date: 2016-07-12 Impact factor: 4.530
Authors: Yoshio Takashima; McKenzie J Fannon; Melissa H Galinato; Noah L Steiner; Michelle An; Alice E Zemljic-Harpf; Sucharita S Somkuwar; Brian P Head; Chitra D Mandyam Journal: Brain Struct Funct Date: 2018-02-13 Impact factor: 3.270
Authors: Jennifer L Stewart; Colm G Connolly; April C May; Susan F Tapert; Marc Wittmann; Martin P Paulus Journal: Addiction Date: 2013-12-15 Impact factor: 6.526